Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development
Ahmad Iftikhar(University of Arizona), Faiz Anwer(Cleveland Clinic), Nathaniel Rosko(Cleveland Clinic), Hamza Hassan(Roswell Park Comprehensive Cancer Center), Adeela Mushtaq(University of Pittsburgh Medical Center), Abraham S. Kanate(HonorHealth), Faryal Razzaq(University of Arizona), Sonia Sandeep(Wilson Community College), Jason Valent(Cleveland Clinic), Nimra Iftikhar(Dow University of Health Sciences), Atif Sohail(Rochester General Hospital), Rajshekhar Chakraborty(Columbia University Irving Medical Center)
Cited by 15
Related Papers
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
|Transplantation and Cellular Therapy|2020|278
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
|Blood|2015|273
PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
|Blood|2017|247